This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Journal Review

Hepatitis B is more prevalent in patients with type 2 diabetes

Research has suggested that hepatitis infection may be a potential risk factor for diabetes. Previous studies have identified a link between hepatitis C infection and type 2 diabetes. However, little work has been done to determine the specific types of diabetes that hepatitis B may influence. A recent Chinese study aimed to investigate the prevalence of chronic hepatitis B (CHB) in patients with various diabetes subtypes.

The study recruited 381 patients with adult-onset autoimmune diabetes, 1365 patients with type 2 diabetes and 1365 non-diabetic controls, excluding patients who were hepatitis C positive, had hepatic cirrhosis, malignant neoplasm or severe renal dysfunction.

Patients with type 2 diabetes were found to have a higher prevalence of CHB than the controls and the patients with adult-onset autoimmune diabetes. There were no differences in the prevalence of CHB between patients with adult-onset autoimmune diabetes and the controls.

The study team concluded that further research is required to determine the specific link between hepatitis B and type 2 diabetes.

References

  1. Lu J, Hou X, Tu H, et al. Hepatitis B virus infection is more prevalent in patients with type 2 diabetes. J Diabetes Investig 2016; doi: 10.1111/jdi.12609